Sharechat Logo

MHJ - Response to ASX Query

Wednesday 10th August 2022

Text too small?

We refer to your letter dated 5 August 2022 regarding the Appendix 3Y lodged by MHJ on 5 August 2022 for Mr Daniel Bracken in respect of 634,081 share rights in MHJ granted to Mr Bracken. 

In response to your specific queries:  

1. The Appendix 3Y was lodged late due to an administrative oversight. The 634,081 share rights granted to Mr Bracken were the first share rights granted to Mr Bracken following his appointment as Managing Director. The Appendix 3Y was lodged promptly upon this oversight being identified. 

2. MHJ confirms it has an agreement in place with each of its directors which require the director to provide to MHJ the information needed by MHJ in order for MHJ to meet its disclosure obligations under Listing Rule 3.19A.  

3. MHJ believes the arrangements it has in place with its directors are adequate. The late lodgement of the Appendix 3Y was due to an administrative oversight and not because the director failed to provide information to MHJ. MHJ has updated its internal company secretary process document and reporting calendar to ensure that this type of oversight does not occur again. 

MHJ notes that the market was aware of the share rights granted to Mr Bracken prior to the lodgement of the Appendix 3Y and that:

at the MHJ AGM on 27 October 2021, MHJ Shareholders approved the grant of 634,081 share rights to Mr Bracken under MHJ's Long Term Incentive Plan for FY22 as part of his long-term incentive arrangements as Managing Director & Chief Executive Officer; and 

the Appendix 3G Notification of issue, conversion or payment up of unquoted equity securities lodged on 28 October 2021 included reference to Mr Bracken being issued 634,081 share rights. 

Response to ASX Query



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b